Bevacizumab targets vascular endothelial growth factor (VEGF) to prevent new abnormal blood vessel formation in the retina, stabilizing or improving vision in patients with retinal diseases.
How does Bevacizumab work in treating eye conditions?
Share This Story, Choose Your Platform!
About the Author: Staff Writer
World Eyecare Foundation staff writers are experienced eye care providers, researchers, academicians, industry leaders and practicing ophthalmologists and optometrist from around the world. Content may be generated by AI and is reviewed by the editorial team and specialists in the areas of publications.
Leave A Comment